Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis.

Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U.

Lancet. 1985 Sep 7;2(8454):515-8.

PMID:
2863541
[PubMed - indexed for MEDLINE]
2.

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.

Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ.

BMJ. 2007 Mar 31;334(7595):674. Epub 2007 Feb 8.

PMID:
17289685
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

Gallus A, Jackaman J, Tillett J, Mills W, Wycherley A.

Lancet. 1986 Dec 6;2(8519):1293-6.

PMID:
2878173
[PubMed - indexed for MEDLINE]
4.

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators.

N Engl J Med. 2001 Jul 19;345(3):165-9.

PMID:
11463010
[PubMed - indexed for MEDLINE]
Free Article
5.

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

Hull R, Delmore T, Carter C, Hirsh J, Genton E, Gent M, Turpie G, McLaughlin D.

N Engl J Med. 1982 Jan 28;306(4):189-94.

PMID:
7033782
[PubMed - indexed for MEDLINE]
6.

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Hull R, Hirsh J, Jay R, Carter C, England C, Gent M, Turpie AG, McLoughlin D, Dodd P, Thomas M, Raskob G, Ockelford P.

N Engl J Med. 1982 Dec 30;307(27):1676-81.

PMID:
6755255
[PubMed - indexed for MEDLINE]
7.

Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.

Hull R, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, McLoughlin D, Armstrong P.

N Engl J Med. 1979 Oct 18;301(16):855-8.

PMID:
384248
[PubMed - indexed for MEDLINE]
8.

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, et al.

Thromb Haemost. 1995 Aug;74(2):606-11.

PMID:
8584992
[PubMed - indexed for MEDLINE]
9.

Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.

Gonzalez-Fajardo JA, Arreba E, Castrodeza J, Perez JL, Fernandez L, Agundez I, Mateo AM, Carrera S, Gutiérrez V, Vaquero C.

J Vasc Surg. 1999 Aug;30(2):283-92.

PMID:
10436448
[PubMed - indexed for MEDLINE]
10.

A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis.

Hull RD, Raskob GE, Hirsh J, Sackett DL.

JAMA. 1984 Jul 13;252(2):235-9.

PMID:
6427492
[PubMed - indexed for MEDLINE]
11.

Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis.

Pini M, Aiello S, Manotti C, Pattacini C, Quintavalla R, Poli T, Tagliaferri A, Dettori AG.

Thromb Haemost. 1994 Aug;72(2):191-7.

PMID:
7831650
[PubMed - indexed for MEDLINE]
12.

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.

Circulation. 2001 May 22;103(20):2453-60.

PMID:
11369685
[PubMed - indexed for MEDLINE]
Free Article
13.

The duration of oral anticoagulation after deep vein thrombosis. A randomized study.

Schulman S, Lockner D, Juhlin-Dannfelt A.

Acta Med Scand. 1985;217(5):547-52.

PMID:
3895828
[PubMed - indexed for MEDLINE]
14.

Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation.

Astermark J, Björgell O, Lindén E, Lethagen S, Nilsson P, Berntorp E.

J Intern Med. 1998 Jul;244(1):79-82.

PMID:
9698028
[PubMed - indexed for MEDLINE]
15.

[Late sequelae of deep venous thrombosis: a 13-year follow-up of 223 patients].

Eichlisberger R, Frauchiger B, Widmer MT, Widmer LK, Jäger K.

Vasa. 1994;23(3):234-43. German.

PMID:
7975869
[PubMed - indexed for MEDLINE]
16.

Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.

[No authors listed]

Prescrire Int. 2013 May;22(138):129-33. Review.

PMID:
23819181
[PubMed - indexed for MEDLINE]
17.

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E.

N Engl J Med. 1997 Feb 6;336(6):393-8.

PMID:
9010144
[PubMed - indexed for MEDLINE]
Free Article
18.

Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.

Kurtoglu M, Koksoy C, Hasan E, Akcalı Y, Karabay O, Filizcan U; TROMBOTEK Study Group.

J Vasc Surg. 2010 Nov;52(5):1262-70. doi: 10.1016/j.jvs.2010.06.070. Epub 2010 Aug 21.

PMID:
20732787
[PubMed - indexed for MEDLINE]
Free Article
19.

Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.

Huisman MV, Bounameaux H.

Semin Vasc Med. 2005 Aug;5(3):276-84.

PMID:
16123915
[PubMed - indexed for MEDLINE]
20.

Studies on the medical treatment of deep vein thrombosis.

Schulman S.

Acta Med Scand Suppl. 1985;704:1-68.

PMID:
3913282
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk